News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

Kostja Paschalidis

Advertisement

Articles by Kostja Paschalidis

The Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business Models

ByKostja Paschalidis,Estelle Ricoux
February 5th 2024

The era of big pharma as product-first companies must end, as services become the larger priority.

Advertisement

Latest Updated Articles

  • The Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business Models
    The Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business Models

    Published: February 5th 2024 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

The Importance of Suppressor Cells in Tumor Progression

2

Johnson and Johnson Acquiring Halda Therapeutics in $3 Billion Definitive Agreement

3

How the FDA Commissioner’s National Priority Vouchers Reshape Manufacturing, Pricing & Global Strategy

4

Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure

5

Agentic AI Will Transform the Business of Life Sciences

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us